L28.1 L28.2
Conditions
Interventions
Group 1: The study is divided into two parts:
In Part 1, after the instrument to be validated (PRO) has been completed, structured interviews are conducted to examine whether it needs to be adjusted
Sponsors
Klinik für Hautkrankheiten und Kompetenzzentrum chronischer Pruritus (KCP), Universitätsklinikum Münster
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Suffering from chronic prurigo
Exclusion criteria
Exclusion criteria: Limitations in understanding the national language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Validation of medical questionnaires for the CPG - Validation of a patient reported outcome tool for patients with CPG | — |
Secondary
| Measure | Time frame |
|---|---|
| -Distribution of pruritus duration, intensity, distribution, localization, associated psychological stress (quality of life, sleep disturbance, emotional stress), previous therapy in the collective examined | — |
Countries
Austria, France, Germany, Italy, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey
Contacts
Public ContactClaudia Zeidler
Klinik für Hautkrankheiten und Kompetenzzentrum chronischer Pruritus (KCP), Universitätsklinikum Münster
Outcome results
None listed